Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer

Prostate

Volumn 71, Issue 8, 2011, Pages 892-898

  Pinski, Jacek ^a   Xiong, Shigang ^a   Wang, Qingcai ^a   Stanczyk, Frank ^a   Hawes, Debra ^a   Liu, Stephen V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; PROGESTERONE; TESTOSTERONE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN LNCAP; CELL VIABILITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; STEROIDOGENESIS; UPREGULATION; WESTERN BLOTTING;

CARCINOMA; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUTEINIZING HORMONE; MALE; PROGESTERONE; PROSTATIC NEOPLASMS; RECEPTORS, LH; TESTOSTERONE; UP-REGULATION;

EID: 79953719387     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21305     Document Type: Article

References (17)

1. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS. Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth. Cancer Res 2008;68:4447-4454.
2. Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res 1998;58:5718-5724. (Pubitemid 29006412)
3. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45. (Pubitemid 33741879)
4. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995;9:401-406.
5. Mohler JL, Gregory CW, Ford OH 3rd, Kim D, Weaver CM, Petrusz P, Wilson EM, French FS. The androgen axis in recurrent prostate cancer. Clin Cancer Res 2004;10:440-448. (Pubitemid 38173980)
6. Page ST, Lin DW, Mostaghel EA, Hess DL, True LD, Amory JK, Nelson PS, Matsumoto AM, Bremner WJ. Persistent intraprostatic androgen concentrations after medical castration in healthy men. J Clin Endocrinol Metab 2006;91:3850-3856. (Pubitemid 44536854)
7. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006;66:2815-2825.
8. Dillard PR, Lin MF, Khan SA. Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Mol Cell Endocrinol 2008;295:115-120.
9. Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME, Nelson CC. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res 2008;68:6407-6415.
10. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormonereceptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997;18:739-773. (Pubitemid 28009566)
11. Goebelsmann U, Horton R, Mestman JH, Arce JJ, Nagata Y, Nakamura RM, Thorneycroft IH, Mishell DR Jr. Male pseudohermaphroditism due to testicular 17 -hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1973;36:867-879.
12. Scott JZ, Stanczyk FZ, Goebelsmann U, Mishell DR. A double-antibody radioimmunoassay for serum progesterone using progesterone-3-(O-carboxymethyl) oximino-[125I]-iodo-histamine as radioligand. Steroids 1978;31:393-405. (Pubitemid 9126236)
13. Serafini P, Ablan F, Lobo RA. 5 alpha-reductase activity in the genital skin of hirsute women. J Clin Endocrinol Metab 1985;60:349-355. (Pubitemid 15129583)
14. Bodek G, Kowalczyk A, Waclawik A, Huhtaniemi I, Ziecik AJ. Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: Functional characteristic and molecular mechanism of cell death pathway. Exp Biol Med (Maywood) 2005;230:421-428. (Pubitemid 40827707)
15. Dirnhofer S, Berger C, Hermann M, Steiner G, Madersbacher S, Berger P. Coexpression of gonadotropic hormones and their corresponding FSH- and LH/CG-receptors in the human prostate. Prostate 1998;35:212-220. (Pubitemid 28211295)
16. Tao YX, Bao S, Ackermann DM, Lei ZM, Rao CV. Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans. Biol Reprod 1997;56:67-72. (Pubitemid 27024163)
17. Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, PlonowskiA, Varga JL, Halmos G.Hypothalamic hormones and cancer. Front Neuroendocrinol 2001;22:248-291.